Pharmspective
Business Services · Missouri, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2 Cityplace Dr Ste 200, St. Louis, Misso...Phone Number
(314) 812-2729Website
www.pharmspective.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Pharmspective
Pharmspective offers a suite of innovative products designed to clarify the healthcare landscape and enhance market access transparency. Their key offerings include AccessAI, a scalable AI solution for commercialization functions, HealthPlanView for formulary and medical policy analysis, and PolicyView for understanding medical policy barriers. Targeting healthcare organizations, Pharmspective aims to simplify the transition to value-based care by providing actionable insights and data analytics. Their mission is to empower healthcare decision-makers by connecting diverse data sources and streamlining access to critical information.Explore more
Pharmspective Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Pharmspective your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Pharmspective recently announced quarterly report
Click to see if Pharmspective had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Pharmspective, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Pharmspective is spiking on competitors!
Funding: Get notified immidiatlly once Pharmspective has new funding data
Check if Pharmspective has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Pharmspective launches new products
Congratulate Masked Content for being promoted to Masked Content at Pharmspective
Recommended Actions
Reach out to Masked Content who joined Pharmspective as Masked Content
Find more new buyers
Compare Similar Companies to Pharmspective
Compare insights from companies similar to Pharmspective, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Pharmspective
<$5M
11-50
Private
-
2012
JM
Jovan MitchellSenior Manager, Healthcare Policy & Payer Reimbursement
Company Profile Activity
Activity Insights
Pharmspective is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Pharmspective is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Pharmspective.
Pharmspective Tech Stack
A closer look at the technologies used by Pharmspective
See more technologies
Pharmspective News & Media
Pharmspective Launches HealthPlanView™ Cost and Coverage Analyzer
ST. LOUIS, Sept. 9, 2019 /PRNewswire/ -- Pharmspective LLC announced today the introduction of HealthPlanView™, the first visual analytics platform built to assess the true drug cost burden to patients and payers. HealthPlanView™ has been designed to address knowledge gaps in the current...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Pharmspective
Sign Up For FreeTo access detailed company insights
Pharmspective offers a suite of innovative products designed to clarify the healthcare landscape and enhance market access transparency. Their key offerings include AccessAI, a scalable AI solution for commercialization functions, HealthPlanView for formulary and medical policy analysis, and PolicyView for understanding medical policy barriers. Tar... Read More
